Potentiation of Large Conductance Kca Channels by Niflumic, Flufenamic, and Mefenamic Acids

Total Page:16

File Type:pdf, Size:1020Kb

Potentiation of Large Conductance Kca Channels by Niflumic, Flufenamic, and Mefenamic Acids 2272 Biophysical Journal Volume 67 December 1994 2272-2279 Potentiation of Large Conductance KCa Channels by Niflumic, Flufenamic, and Mefenamic Acids M. Ottolia and L. Toro Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030 USA ABSTRACT Large conductance calcium-activated K+ (Kca) channels are rapidly activated by niflumic acid dose- dependently and reversibly. External niflumic acid was about 5 times more potent than internal niflumic acid, and its action was characterized by an increase in the channel affinity for [Ca2l], a parallel left shift of the voltage-activation curve, and a decrease of the channel long-closed states. Niflumic acid applied from the external side did not interfere with channel block by charybdotoxin, suggesting that its site of action is not at or near the charybdotoxin receptor. Accordingly, partial tetraethylammonium blockade did not interfere with channel activation by niflumic acid. Flufenamic acid and mefenamic acid also stimulated KCa channel activity and, as niflumic acid, they were more potent from the external than from the internal side. Fenamates applied from the external side displayed the following potency sequence: flufenamic acid niflumic acid >> mefenamic acid. These results indicate that KCa channels possess at least one fenamatereceptor whose occupancy leads to channel opening. INTRODUCTION Large conductance calcium-activated K channels are present quently purified in a sucrose gradient. Membranes obtained from the of cell types (Latorre et al., 1989; McManus, 1991). 20%:25% and 25%:30% (w/w) sucrose interface were used. Lipid bi- in a variety layers were cast from a phospholipid solution in n-decane containing a In neurons they may regulate cell firing (Gola and Crest, 1993), 5:2:3 mixture of phosphatidylethanolamine/phosphatidylserine/phos- and in smooth muscle they seem to play an important role in phatidylcholine (25 mg/ml). The voltage control side was the cis cham- maintaining visceral and vascular tone (Brayden and Nelson, ber, and the trans chamber was referred to ground. Membrane vesicles 1992; Suarez-Kurtz et al., 1991; Anwer et al., 1993; Khan et al., were applied on top of the preformed bilayer from the cis side. The activate this type of channels from the laterality of channel incorporation was determined by the voltage de- 1993). Thus, drugs that pendence of channel gating. external side or internal side (McManus et al., 1993) should be The effect of niflumic acid was tested on reconstituted KCa channels valuable pharmacological tools to modify cellular excitability, as from coronary smooth muscle with low open probability ('0.25). The well as to unveil mechanisms of Kca channel function. experimental solutions were, for the cis chamber (mM): 250 KCl, 10 Niflumic and flufenamic acids are nonsteroidal anti- MOPS, 1 HEDTA, 0.67 CaCl2 (pH 7.2, pCa 5.17); for the trans chamber compounds (Hoffmann and Faure, 1966; (mM): 5 KCI, 245 NaCl, 10 MOPS, 1 HEDTA, 0.67 CaCl2 (pH 7.20, inflammatory aromatic pCa 5.17). Variations to these solutions are indicated in the figure leg- Kohler et al., 1992) known to inhibit Cl- conductances (White ends. Calcium-activation curves were constructed by perfusing solu- and Aylwin, 1990; Korn et al., 1991; McCarty et al., 1993) and tions with different [Ca2+]i, calculated according to Fabiato (1988). A nonselective cationic channels (Gogelein et al., 1990). Recently, rapid perfusion system for a bilayer setup ('15-30 s) was used to a calcium-independent K current from jejunum smooth muscle exchange solutions. has been shown to be increased by fe- Data were acquired on line at 1 ms/point and filtered at 500 Hz using and corneal epithelium an 8-pole Bessel filter. Analysis was performed using TRANSIT (A. M. namates (Rae and Farrugia, 1992; Farrugia et al., 1993a, b). We J. VanDongen, Duke University, Chapel Hill, NC). Open probability now demonstrate that flufenamic niflumic>> mefenamic ac- was obtained from the ratio between the open time and the total time. ids can activate large conductance K,> channels from the ex- Kinetic analysis was performed in bilayers with a single channel. manner. Part ofthis work has A critical closed time of 1 s was used to obtain charybdotoxin- ternal side in a rapid and reversible ± in abstract form et al., 1993). induced blocked and unblocked times. Values are means SEM. A been presented (Foro one-tailed Student's t-test, or ANOVA and multiple comparison Tukey tests were applied; values were considered significantly different at a level p ' 0.05. MATERIALS AND METHODS Niflumic acid, mefenamic acid, and flufenamic acids were purchased Chemical Co. (St. Louis, MO). Concentrated stock solutions Coronary smooth muscle membrane vesicles were obtained as described from Sigma mM) of niflumic and flufenamic acids were done in ethanol, whereas in Toro et al. (1991). Briefly, plasma membrane vesicles from pig coro- (100 acid stock solution (100 mM) was prepared in 1:1 ethanol:dim- smooth muscle were prepared from 20 or 30 arteries. Microsomes mefenamic nary Final dilutions had a pH of 7.20 and contained at were obtained in the presence of proteases inhibitors and were subse- ethylsulfoxide (DMSO). most 1% ethanol or 0.05% DMSO. These concentrations of solvent did not increase by themselves the channel open probability. Receivedforpublication 22 February 1994 and infinalform 26 May 1994. RESULTS AND DISCUSSION Address reprint requests to Ligia Toro, Ph.D., Dept. Anesthesiology, UCLA School of Medicine, Rm. BH612 CHS, 10833 Le Conte Ave. Los Angeles, Niflumic acid activates KCa channels from the CA 90024. external side in a dose-dependent, fast, Authors' present address: Dept. Anesthesiology, University of California at and reversible manner Los Angeles, Los Angeles, CA 90024. X) 1994 by the Biophysical Society The action of niflumic acid on KCa channels from coronary 0006-3495/94/12/2272/08 $2.00 smooth muscle reconstituted into lipid bilayers was explored. Ottolia and Toro Fenamates as Kc, Channel Agonists 2273 Micromolar concentrations of niflumic acid from the exter- illustrates the activity of a channel under control conditions nal side caused an increase in channel open probability (P.) ([Ca2]i = 7 ,M), after diminution of channel activity by (60 out of 64 studied channels). For example, in 10 experi- lowering [Ca2"]i to 3 ,uM with a calcium chelator (HEDTA), ments with 100 ,uM niflumic acid channel P. increased from and its fast increase after external perfusion of niflumic acid. 0.09 ± 0.01 to 0.35 ± 0.05. When dose-response curves were The lower panel illustrates in another experiment that ni- constructed, the Kd was 261 ± 73 ,uM (n = 5) and the Hill flumic acid-induced increase ofKc. channel activity could be coefficient approximated 1 (0.99 ± 0.12). Fig. 1 A exem- readily reversed after washing out the drug. It seems, there- plifies a channel with a Kd of 132 ,uM and a Hill coefficient fore, that Kc. channels possess a specific niflumic acid re- of 0.6. A Hill coefficient near one indicates that the poten- ceptor. Furthermore, it is very likely that this receptor is tiation of Kca channels by niflumic acid involves a bimo- located in the channel protein and not in a closely asso- lecular interaction between the drug and its binding site. The ciated molecule because we have observed that external stimulatory effect of externally applied niflumic acid was niflumic is also able to stimulate a cloned KCa channel also observed in Kc. channels from other sources like uterine reconstituted in lipid bilayers (Perez et al., 1994; our un- and tracheal smooth muscle, slo Kca channel expressed in published observations). oocytes and from skeletal muscle. For example, 100 ,uM niflumic acid caused an increase in channel PO from the first three sources from 0.37 to 0.71, from 0.3 to 0.8, and from Mechanism of niflumic acid activation 0.21 to 0.55, respectively. of Kca channels Niflumic acid action took place within the time resolution Because KCa channels are voltage- and calcium-sensitive, we of our perfusion system (15-30 s), and its effect was readily decided to study whether niflumic acid affected these chan- washed out (P.-.ntro = 0.05 ± 0.01; Po-niflumic acid = 032 + nel properties. We found that niflumic acid from the external 0.07; Pw,,ashout = 0.047 ± 0.01; n = 3) even if a high dose side exerted its effect on Kc. channels by left-shifting both of niflumic acid was used. Fig. 1 B shows the time course of their voltage- and calcium-activation curves without major two such experiments where 1 mM niflumic acid was per- changes in the slopes of the curves. Fig. 2 A shows that fused to the external side of the channel. The upper graph perfusion of 100 ,uM niflumic acid to the external side in- A B Control HEDTA Niflumic Ac. Control Intemal Extemal 4- *- J , 15 pA Niflumic acid 1.0 Ts lW,UM~~~~~~~~~~~~~~~~~~~' 0.8 0.6 I1 500,uM 0.4 0.2 0.0 500 ms 0 50 100 150 200 300 Time, s 1.0 I 0.8 Control lmM Washout 0.6 +1M~m I5p1 .0 0 1.0 - 0.4 5 0.8- .0 0.6- 0.2 t 0.4- 0.0 -2 10 1 10 10 104 o 50 15DU AU 300 350 [Niflumic acid], #M Time, s FIGURE 1 Niflumic acid activates Kc channels. The action of external niflumic acid on Ca2+-activated K+ (KCa) channels was assessed using pig coronary smooth muscle plasma membranes incorporated into lipid bilayers. (A) Records illustrating Kc. channel activation by niflumic acid at different [niflumic acid], and corresponding dose-response curve. Experimental data were fitted to: Normalized PO = (1 - A)/(1 + (K112/[niflumic acid])N) + A, where K,12N = Kd and A is the channel P.
Recommended publications
  • Colitis Caused by Non-Steroidal Anti-Inflammatory Drugs
    Postgrad Med J: first published as 10.1136/pgmj.62.730.773 on 1 August 1986. Downloaded from Postgraduate Medical Journal (1986) 62, 773-776 Colitis caused by non-steroidal anti-inflammatory drugs S. Ravi', A.C. Keat2 and E.C.B. Keat1 'Cuckfield Hospital, Cuckfield, West Sussex, and2Westminster Hospital, Horseferry Road, London SWIP2AP, UK. Summary: Four cases of acute proctocolitis associated with non-steroidal anti-inflammatory drug therapy are presented. The drugs implicated were flufenamic acid, mefenamic acid, naproxen and ibuprofen. After resolution of symptoms and signs of proctocolitis three of the four patients were subsequently rechallenged with the implicated drug: in each there was a rapid relapse. Introduction Ulcerative colitis is a disease of unknown aetiology Case reports with characteristic clinical features and a protracted course. A similar clinical picture, but running a shorter Case I and usually benign course, is occasionally seen follow- ing the administration of certain drugs. This was first A 77 year old woman was referred with intermittent noticed following the administration of antibiotics, bleeding per rectum for 6 months, associated for the often with pseudomembrane formation. Later, this last 2 months with bloody diarrhoea up to eight times was shown to be associated with infection by toxigenic daily. Previously, she had had troublesome symptoms Clostridium difficile. Until 1978, most cases were from osteoarthritis of her back and knees for which copyright. associated with treatment with clindamycin but since she had been prescribed flufenamic acid 200 mg thrice that time nearly all antibiotics have been implicated. daily. Her general health had remained good but she Other drugs capable of causing proctocolitis, though appeared pale and her haemoglobin was reduced to by different mechanisms, include phenindione (Keat & 8 g/dl.
    [Show full text]
  • Effect of Hypercholesterolaemia on Voltage-Operated Calcium Channel Currents in Rabbit Arterial Smooth Muscle Cells
    Journal of Human Hypertension (1999) 13, 849–853 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Effect of hypercholesterolaemia on voltage-operated calcium channel currents in rabbit arterial smooth muscle cells GF Clunn, S Wijetunge and AD Hughes Clinical Pharmacology, NHLI, St. Mary’s Hospital, Imperial College of Science, Technology and Medicine, South Wharf Road, London, W2 1NY, UK Cholesterol is a major component of cell membranes capacitance was also greater in NZ cells. Consequently, and influences membrane fluidity. Watanabe heritable there was no significant difference in current density hyperpercholesterolaemic rabbits (WHHL) possess between NZ and WHHL cells either in the absence of defective receptors for low density lipoprotein leading drug or in the presence of the calcium channel agonist to increased plasma cholesterol, accumulation of chol- (+)202 791. Current voltage-relationships, kinetics of esterol in the arterial wall and atherosclerosis. In this fast inactivation and steady-state inactivation of IBa also study calcium channel currents (IBa) were compared did not differ significantly between WHHL and NZ. These using conventional whole cell voltage clamp techniques findings suggest that hypercholesterolaemia in WHHL in ear artery cells isolated from control New Zealand has no direct effect on calcium channel current density White rabbits (NZ) with those from WHHL. IBa were larger or voltage-modulation in arterial smooth muscle cells. in cells isolated from NZ than from WHHL, however cell Keywords: calcium channel; cholesterol; vascular smooth muscle; Watanabe hypercholesterolaemic rabbit Introduction atic cholesterol toxicity or other organ damage which develops in cholesterol-fed rabbits.15 WHHL Cholesterol is a major component of cell membranes 1,2 has therefore been proposed to be a model of human and influences membrane structure and fluidity.
    [Show full text]
  • Investigating the Influence of Polymers on Supersaturated
    Page 1 of 45 Molecular Pharmaceutics 1 2 3 4 5 6 7 Investigating the Influence of Polymers on 8 9 10 11 12 Supersaturated Flufenamic Acid Cocrystal Solutions 13 14 15 16 1 1 2 2 1 17 Minshan Guo , Ke Wang , Noel Hamill , Keith Lorimer and Mingzhong Li * 18 19 20 1School of pharmacy, De Montfort University, Leicester, UK 21 22 23 2Almac Science, Seagoe Industrial Estate, Craigavon, UK 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ACS Paragon Plus Environment 1 Molecular Pharmaceutics Page 2 of 45 1 2 3 4 5 6 7 Table of contents graphic 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ACS Paragon Plus Environment 2 Page 3 of 45 Molecular Pharmaceutics 1 2 3 Abstract 4 5 6 7 The development of enabling formulations is a key stage when demonstrating the effectiveness 8 9 10 of pharmaceutical cocrystals to maximize the oral bioavailability for poorly water soluble drugs. 11 12 Inhibition of drug crystallization from a supersaturated cocrystal solution through a fundamental 13 14 understanding of the nucleation and crystal growth is important. In this study, the influence of 15 16 17 the three polymers of polyethylene glycol (PEG), polyvinylpyrrolidone (PVP) and a copolymer 18 19 of N-vinly-2-pyrrodidone (60%) and vinyl acetate (40%) (PVP-VA) on the flufenamic acid 20 21 22 (FFA) crystallization from three different supersaturated solutions of the pure FFA and two 23 24 cocrystals of FFA-NIC CO and FFA-TP CO has been investigated by measuring nucleation 25 26 induction times and desupersaturation rates in the presence and absence of seed crystals.
    [Show full text]
  • Big Pain Assays Aren't a Big Pain with the Raptor Biphenyl LC Column
    Featured Application: 231 Pain Management and Drugs of Abuse Compounds in under 10 Minutes by LC-MS/MS Big Pain Assays Aren’t a Big Pain with the Raptor Biphenyl LC Column • 231 compounds, 40+ isobars, 10 drug classes, 22 ESI- compounds in 10 minutes with 1 column. • A Raptor SPP LC column with time-tested Restek Biphenyl selectivity is the most versatile, multiclass-capable LC column available. • Achieve excellent separation of critical isobars with no tailing peaks. • Run fast and reliable high-throughput LC-MS/MS analyses with increased sensitivity using simple mobile phases. The use of pain management drugs is steadily increasing. As a result, hospital and reference labs are seeing an increase in patient samples that must be screened for a wide variety of pain management drugs to prevent drug abuse and to ensure patient safety and adherence to their medication regimen. Thera- peutic drug monitoring can be challenging due to the low cutoff levels, potential matrix interferences, and isobaric drug compounds. To address these chal- lenges, many drug testing facilities are turning to liquid chromatography coupled with mass spectrometry (LC-MS/MS) for its increased speed, sensitivity, and specificity. As shown in the analysis below, Restek’s Raptor Biphenyl column is ideal for developing successful LC-MS/MS pain medication screening methodologies. With its exceptionally high retention and unique selectivity, 231 multiclass drug compounds and metabolites—including over 40 isobars—can be analyzed in just 10 minutes. In addition, separate panels have been optimized on the Raptor Biphenyl column specifically for opioids, antianxiety drugs, barbiturates, NSAIDs and analgesics, antidepressants, antiepileptics, antipsychotics, hallucinogens, and stimulants for use during confirmation and quantitative analyses.
    [Show full text]
  • Flufenamic Acid, Mefenamic Acid and Niflumic Acid Inhibit Single Nonselective Cation Channels in the Rat Exocrine Pancreas
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Volume 268, number 1, 79-82 FEBS 08679 July 1990 Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas H. Gagelein*, D. Dahlem, H.C. Englert** and H.J. Lang** Max-Planck-Institutfir Biophysik, Kennedyallee 70, D-600 Frankfurt/Main 70, FRG Received 17 May 1990 The non-steroidal anti-inflammatory drugs, flufenamic acid, mefenamic acid and niflumic acid, block Ca2+-activated non-selective cation channels in inside-out patches from the basolateral membrane of rat exocrine pancreatic cells. Half-maximal inhibition was about 10 PM for flufenamic acid and mefenamic acid, whereas niflumic acid was less potent (IC,, about 50 PM). Indomethacin, aspirin, diltiazem and ibuprofen (100 /IM) had not effect. It is concluded that the inhibitory effect of flufenamate, mefenamate and niflumate is dependent on the specific structure, consisting of two phenyl rings linked by an amino bridge. Mefenamic acid; Flufenamic acid; Niflumic acid; Indomethacin; Non-selective cation channel; Rat exocrine pancreas 1. INTRODUCTION indomethacin, ibuprofen, diltiazem and acetylsalicylic acid (aspirin) were obtained from Sigma (Munich, FRG). The substances were dissolved in dimethylsulfoxide (DMSO, Merck, Darmstadt, FRG, Recently it was reported that the drug, 3 ’ ,5-dichloro- 0.1% of total volume) before addition to the measuring solution. diphenylamine-2-carboxylic acid (DCDPC), blocks DMSO alone had no effect on the single channel recordings. non-selective cation channels in the basolateral mem- 2.2. Methods brane of rat exocrine pancreatic cells [ 11.
    [Show full text]
  • Synthesis and Pharmacological Evaluation of Fenamate Analogues: 1,3,4-Oxadiazol-2-Ones and 1,3,4- Oxadiazole-2-Thiones
    Scientia Pharmaceutica (Sci. Pharm.) 71,331-356 (2003) O Osterreichische Apotheker-Verlagsgesellschaft m. b.H., Wien, Printed in Austria Synthesis and Pharmacological Evaluation of Fenamate Analogues: 1,3,4-Oxadiazol-2-ones and 1,3,4- Oxadiazole-2-thiones Aida A. ~l-~zzoun~'*,Yousreya A ~aklad',Herbert ~artsch~,~afaaA. 2aghary4, Waleed M. lbrahims, Mosaad S. ~oharned~. Pharmaceutical Sciences Dept. (Pharmaceutical Chemistry goup' and Pharmacology group2), National Research Center, Tahrir St. Dokki, Giza, Egypt. 3~nstitutflir Pharmazeutische Chemie, Pharrnazie Zentrum der Universitilt Wien. 4~harmaceuticalChemistry Dept. ,' Organic Chemistry Dept. , Helwan University , Faculty of Pharmacy, Ein Helwan Cairo, Egypt. Abstract A series of fenamate pyridyl or quinolinyl analogues of 1,3,4-oxadiazol-2-ones 5a-d and 6a-r, and 1,3,4-oxadiazole-2-thiones 5e-g and 6s-v, respectively, have been synthesized and evaluated for their analgesic (hot-plate) , antiinflammatory (carrageenin induced rat's paw edema) and ulcerogenic effects as well as plasma prostaglandin E2 (PGE2) level. The highest analgesic activity was achieved with compound 5a (0.5 ,0.6 ,0.7 mrnolkg b.wt.) in respect with mefenamic acid (0.4 mmollkg b.wt.). Compounds 6h, 61 and 5g showed 93, 88 and 84% inhibition, respectively on the carrageenan-induced rat's paw edema at dose level of O.lrnrnol/kg b.wt, compared with 58% inhibition of mefenamic acid (0.2mmoll kg b.wt.). Moreover, the highest inhibitory activity on plasma PGE2 level was displayed also with 6h, 61 and 5g (71, 70,68.5% respectively, 0.lmmolkg b.wt.) compared with indomethacin (60%, 0.01 mmolkg b.wt.) as a reference drug.
    [Show full text]
  • Choice of Drugs in the Treatment of Rheumatoid Arthritis
    RHEUMATOLOGY IN GENERAL PRACTICE 7 Those with predominant but never exclusive involvement of the terminal finger joint, usually associated with changes in the nail of the same finger; they are serologically negative. There may be a swollen finger with loss of the skin markings-a sort of dactylitis, again serologically negative. (2) Those with a much more severe process which produces loss of movement in the spine and changes in the sacroiliac joints much the same as those in ankylosing spondylitis; unlike ankylosing spondylitis, it produces severe deformity often with ankylosis in peripheral joints. Many of the finger joints become deformed and ankylosed. (3) Those cases indistinguishable from rheumatoid arthritis although the majority are sero-negative. The Stevens Johnson syndrome produces acute effusions, particularly in large joints. It is sometimes associated with the rash of erythema multiforme, always with ulceration in the mouth and genital tract; the mouth ulcers are accompanied by sloughing, unlike those of Beh9et's syndrome which we come to next. BehCet's syndrome, originally described as a combination of orogenital ulceration with relapsing iritis, is now expanded to include skin lesions, other eye lesions, lesions of the central nervous system, thrombophlebitis migrans, and arthropathy (occurring in 64 per cent). The onset is acute, often affecting only a single joint and settling without residual trouble. Choice of drugs in the treatment of rheumatoid arthritis Dr Dudley Hart, M.D., F.R.C.P. (Consultant physician, Westminster Hospital and Medical School) There are many potential drugs for the treatment of rheumatoid disease, but what are we treating in this disorder? Pain in rheumatoid arthritis is but one of the symp- toms.
    [Show full text]
  • Rheumatoid Arthritis Evaluation of Methods and a Comparison of Mefenamic and Flufenamic Acids with Phenylbutazone and Aspirin by R
    Ann Rheum Dis: first published as 10.1136/ard.26.5.373 on 1 September 1967. Downloaded from Ann. rheum. Dis. (1967), 26, 373 ASSESSMENT OF DRUGS IN OUT-PATIENTS WITH RHEUMATOID ARTHRITIS EVALUATION OF METHODS AND A COMPARISON OF MEFENAMIC AND FLUFENAMIC ACIDS WITH PHENYLBUTAZONE AND ASPIRIN BY R. M. MASON, D. E. BARNARDO*, W. R. FOXt, AND M. WEATHERALL+ From the Department ofPhysical Medicine and Rheumatology, the London Hospital, and the Department ofPharmacology, the London Hospital Medical College Relief of symptoms in patients with chronic The methods of clinical trials are still capable of rheumatoid arthritis is difficult. Conventional much improvement. Particularly in trials on out- analgesics such as aspirin, paracetamol, and phenyl- patients, the opportunities for undetected errors are butazone have limited efficacy and are not free from very great. Problems of measurement are also toxic effects. Any alternative which was more considerable, at least in rheumatoid arthritis, in effective, safer, or both would be welcome, but most which all of the many measurements which can be copyright. new remedies owe such success as they achieve to made appear to vary somewhat independently of therapeutic optimism which is a powerful but each other (American Rheumatism Association, transient potentiator of pharmacological effects. 1965), so that confidence in any one is limited. The accurate assessment of new drugs by properly One cannot decide which is the best of a number of controlled trials is indispensable. Two drugs which alternative procedures without testing all of them in have shown promise in laboratory studies and early parallel. The present trial has been extended clinical trials are mefenamic and flufenamic acids considerably beyond the needs of a simple compari- (Winder, Wax, Scotti, Scherrer, Jones, and Short, son of drugs in order also to be informative about 1962; Goodley, 1963; Young, 1962), derivatives of problems of method.
    [Show full text]
  • S1 Table. List of Medications Analyzed in Present Study Drug
    S1 Table. List of medications analyzed in present study Drug class Drugs Propofol, ketamine, etomidate, Barbiturate (1) (thiopental) Benzodiazepines (28) (midazolam, lorazepam, clonazepam, diazepam, chlordiazepoxide, oxazepam, potassium Sedatives clorazepate, bromazepam, clobazam, alprazolam, pinazepam, (32 drugs) nordazepam, fludiazepam, ethyl loflazepate, etizolam, clotiazepam, tofisopam, flurazepam, flunitrazepam, estazolam, triazolam, lormetazepam, temazepam, brotizolam, quazepam, loprazolam, zopiclone, zolpidem) Fentanyl, alfentanil, sufentanil, remifentanil, morphine, Opioid analgesics hydromorphone, nicomorphine, oxycodone, tramadol, (10 drugs) pethidine Acetaminophen, Non-steroidal anti-inflammatory drugs (36) (celecoxib, polmacoxib, etoricoxib, nimesulide, aceclofenac, acemetacin, amfenac, cinnoxicam, dexibuprofen, diclofenac, emorfazone, Non-opioid analgesics etodolac, fenoprofen, flufenamic acid, flurbiprofen, ibuprofen, (44 drugs) ketoprofen, ketorolac, lornoxicam, loxoprofen, mefenamiate, meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, pranoprofen, proglumetacin, sulindac, talniflumate, tenoxicam, tiaprofenic acid, zaltoprofen, morniflumate, pelubiprofen, indomethacin), Anticonvulsants (7) (gabapentin, pregabalin, lamotrigine, levetiracetam, carbamazepine, valproic acid, lacosamide) Vecuronium, rocuronium bromide, cisatracurium, atracurium, Neuromuscular hexafluronium, pipecuronium bromide, doxacurium chloride, blocking agents fazadinium bromide, mivacurium chloride, (12 drugs) pancuronium, gallamine, succinylcholine
    [Show full text]
  • Pharmaceutical and Veterinary Compounds and Metabolites
    PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES High quality reference materials for analytical testing of pharmaceutical and veterinary compounds and metabolites. lgcstandards.com/drehrenstorfer [email protected] LGC Quality | ISO 17034 | ISO/IEC 17025 | ISO 9001 PHARMACEUTICAL AND VETERINARY COMPOUNDS AND METABOLITES What you need to know Pharmaceutical and veterinary medicines are essential for To facilitate the fair trade of food, and to ensure a consistent human and animal welfare, but their use can leave residues and evidence-based approach to consumer protection across in both the food chain and the environment. In a 2019 survey the globe, the Codex Alimentarius Commission (“Codex”) was of EU member states, the European Food Safety Authority established in 1963. Codex is a joint agency of the FAO (Food (EFSA) found that the number one food safety concern was and Agriculture Office of the United Nations) and the WHO the misuse of antibiotics, hormones and steroids in farm (World Health Organisation). It is responsible for producing animals. This is, in part, related to the issue of growing antibiotic and maintaining the Codex Alimentarius: a compendium of resistance in humans as a result of their potential overuse in standards, guidelines and codes of practice relating to food animals. This level of concern and increasing awareness of safety. The legal framework for the authorisation, distribution the risks associated with veterinary residues entering the food and control of Veterinary Medicinal Products (VMPs) varies chain has led to many regulatory bodies increasing surveillance from country to country, but certain common principles activities for pharmaceutical and veterinary residues in food and apply which are described in the Codex guidelines.
    [Show full text]
  • Siteand Mechanism of Action of Resin Acids on Voltage-Gated Ion Channels
    Linköping University Medical Dissertation No. 1620 Site and Mechanism of Action of Resin Acids on Voltage-Gated Ion Channels Malin Silverå Ejneby Department of Clinical and Experimental Medicine Linköping University, Sweden Linköping 2018 © Malin Silverå Ejneby, 2018 Cover illustration: “The Charged Pine Tree Anchored to the Ground” was designed and painted by Daniel Silverå Ejneby. Printed in Sweden by LiU-Tryck, Linköping, Sweden, 2018 ISSN: 0345-0082 ISBN: 978-91-7685-318-4 TABLE OF CONTENTS ABSTRACT ............................................................................................................................... 1 POPULÄRVETENSKAPLIG SAMMANFATTNING ................................................................. 3 LIST OF ARTICLES .................................................................................................................. 5 INTRODUCTION ....................................................................................................................... 7 Ions underlie the electrical activity in the heart and brain .................................................. 7 A mathematical model for the nerve impulse - Hodgkin and Huxley ............................... 7 Cardiac action potentials – a great diversity of shapes ...................................................... 9 Voltage-gated ion channels ......................................................................................................... 9 General structure ....................................................................................................................
    [Show full text]
  • Drug and Medication Classification Schedule
    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
    [Show full text]